France: Eurazeo becomes minority shareholder in Moria alongside Naxicap Partners
The Nov Santé fund, managed by France-based private equity firm Eurazeo, has made an investment in Moria Surgical, a leading French player specialized in...
Germany: Exyte acquires TTP Group to accelerate growth of biopharma and life sciences business
Exyte, a Germany-based company operating in in the design, engineering, and delivery of high-tech facilities, intends to acquire TTP Group, an engineering firm specializing...
The Netherlands: Qiagen announces final terms on US$500m convertible bonds
Qiagen, a listed multinational provider of sample and assay technologies for molecular diagnostics, has set the final terms of its US$500m 2.5% convertible bonds...
France: Bruker makes strategic minority investment in NovAliX
Bruker, a developer, manufacturer and distributor of high-performance scientific instruments and analytical and diagnostic solutions, has taken a minority ownership stake in NovAliX, a...
Malaysia: IHH Healthcare expands footprint in Penang with acquisition of Island Hospital from Affinity...
IHH Healthcare, a Malaysia-based global integrated healthcare provider, is strengthening its leadership position in its home country with the acquisition of the 600-bed capacity...
Finland: DevCo closes a €616m long-term single-asset investment vehicle for Medix Biochemica
DevCo Partners, an investment company founded by Otto Kukkonen, Teemu Alahuhta, and Lauri Stadigh, which supports medium-sized Nordic companies, has raised €616m i(US$681m) in capital...
Switzerland: EGS Beteiligungen raises stake in Siegfried with exercise of convertible bond
EGS Beteiligungen, the investment arm of the Ernst Göhner Foundation, has exercised its right to convert Siegfried convertible bonds issued in December 2020 with...
Lithuania: Affidea expands country presence with acquisition of Synlab Lithuania
Affidea, a pan-European provider of polyclinics, advanced diagnostic imaging, and specialist healthcare services, has expanded its presence in Lithuania by acquiring Synlab Lithuania, a...
Switzerland: Galderma places inaugural CHF500m two-tranche bond
Galderma, the SIX Swiss-listed pure play dermatology company, has placed an inaugural CHF500m (US$589m) two-tranche bond offering:
CHF250m four-year paying a 1.6% fixed-rate annual coupon
CHF250m...
France: Archimed acquires anti-microbial wound irrigation solutions company Irrimax
France-based private equity healthcare specialist Archimed has acquired Irrimax Corporation (including its holding company, Innovation Technologies) for an undisclosed sum. US-based Irrimax, founded in...
Advertisement
